Active Ingredient: ACETAMINOPHEN; IBUPROFEN SODIUM
Proprietary Name: COMBOGESIC IV
Dosage Form; Route of Administration: SOLUTION; INTRAVENOUS
Strength: 1GM/100ML (10MG/ML);EQ 300MG BASE/100ML (EQ 3MG BASE/ML)
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N215320
Product Number: 001
Approval Date: Oct 17, 2023
Applicant Holder Full Name: HIKMA PHARMACEUTICALS USA INC
Marketing Status:
Prescription
Patent and Exclusivity Information
